TrialInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2015

Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study.

Karen Sayal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.